Does Ozempic cause cancer?
There is no strong evidence that Ozempic (semaglutide) causes cancer in humans. However, it carries an FDA boxed warning for the risk of thyroid C-cell tumors based on animal studies.
In laboratory studies, semaglutide caused thyroid tumors, including cancerous ones, in mice and rats. It is unknown if the same effect occurs in humans. Clinical trials have not found evidence of increased cancer risk, though some thyroid cancer cases have been reported in patients taking GLP-1 agonists like Ozempic and liraglutide.
Ozempic is not recommended for individuals with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2). Patients should be aware of potential thyroid tumor symptoms, including:
- A lump in the neck
- Difficulty swallowing
- Shortness of breath
- Hoarseness
Speak with your healthcare provider if you have concerns about cancer risk.
What is Ozempic?
Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist that is injected weekly to:
- Treat type 2 diabetes in adults
- Reduce the risk of major cardiovascular events in adults with type 2 diabetes and heart disease
- Reduce the risk of worsening kidney disease and death due to heart problems in adults with type 2 diabetes and chronic kidney disease
- Support weight loss (off-label use)
What Does Research Say About Ozempic and Cancer Risk?
Studies on Ozempic’s cancer risk in humans have been mixed, with most not showing an increased risk.
Studies Finding No Increased Cancer Risk
- 2019 meta-analysis (36,000 patients, 1.7 years follow-up): No link between GLP-1 agonists and pancreatic cancer.
- 2023 meta-analysis (37 clinical trials, 19 real-world studies): No increased risk of any cancer with semaglutide.
- 2024 systematic review: Thyroid cancer incidence in semaglutide users was less than 1%, suggesting no significant risk.
- 2024 cohort study (1.6 million patients): GLP-1 agonists lowered the risk of 10 out of 13 obesity-related cancers compared to insulin.
Studies Suggesting a Possible Cancer Link
- 2022 study (FDA Adverse Events Reporting System - FAERS): Found an increased reporting rate of some tumors in patients taking GLP-1 agonists with dipeptidyl-peptidase IV inhibitors.
- 2023 FAERS study: Found an association between GLP-1 agonists like Ozempic and pancreatic cancer.
Related questions
- Mounjaro vs Ozempic: Which is right for you?
- Ozempic Side Effects to Watch For
- What are the long-term side effects of Ozempic?
Should You Be Concerned About Cancer Risk With Ozempic?
While some studies suggest a potential link to pancreatic cancer, large-scale clinical trials have not confirmed this risk. More research is needed to determine whether GLP-1 agonists increase or decrease cancer risk. Discuss the risks and benefits of Ozempic with your healthcare provider to determine if it is the right medication for you.
This is not all the information you need to know about Ozempic (semaglutide) for safe and effective use and does not take the place of your doctor’s directions. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.
References
Cao, M., et. al. 2023. Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis. In: International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-023-01556-2
Feier, C. V., et. al. 2024. Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review. In: International Journal of Molecular Sciences. DOI: https://doi.org/10.3390/ijms25084346
Nagendra, L., et. al. 2023. Semaglutide and cancer: A systematic review and meta-analysis. In: Diabetes and Metabolic Syndrome. DOI: https://doi.org/10.1016/j.dsx.2023.102834
Nauck, M. A., et. al. 2013. Do GLP-1–Based Therapies Increase Cancer Risk? In: Diabetes Care. DOI: https://doi.org/10.2337/dcS13-2004
Ozempic [package insert]. Updated November 2024. Novo Nordisk. Accessed 11/16/2024 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
Pinto, L. C., et. al. 2019. Glucagon-like peptide-1 receptor agonists and pancreatic cancer: a meta-analysis with trial sequential analysis. In: Nature Scientific Reports. DOI: https://doi.org/10.1038/s41598-019-38956-2
Yang, Z., et. al. 2022. GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS. In: Frontiers in Pharmacology. DOI: https://doi.org/10.3389/fphar.2022.925377
Read next
How do Ozempic, Mounjaro, Wegovy, Zepbound compare for weight loss?
Ozempic, Mounjaro, Wegovy and Zepbound can all lead to long-term weight loss, but only Wegovy and Zepbound are approved by the FDA for this use. In studies, Zepbound has led to a 21% weight loss in adults using the highest dose, while Wegovy has led to about a 15% weight loss. Continue reading
How long does it take for Ozempic to work?
Your blood glucose (sugar) levels should start to fully decline within the first week after you start using Ozempic (semaglutide) at your regular dose. However, the full effect can take 8 weeks or longer, as this is a long-acting medication that is injected only once per week. Continue reading
Wegovy vs Ozempic: Which is Right for You?
Both Wegovy and Ozempic contain semaglutide, but Wegovy is prescribed for long-term weight management while Ozempic is used to control blood sugar levels in type 2 diabetes and help protect kidney function. They both lower the risk for heart-related complications, but they differ in other approved uses, doses, target populations and costs. Continue reading
See also:
Aimovig
Learn about Aimovig (erenumab-aooe) a once-monthly, injectable medication that can be ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Vyepti
Vyepti (eptinezumab-jjmr) is used for the preventive treatment of migraine. Includes Vyepti ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Topamax
Topamax (topiramate) is used to prevent seizures in adults and children and to prevent migraine ...
Emgality
Emgality (galcanezumab-gnlm) is a CGRP antagonist for the preventive treatment of migraine and for ...
Inderal
Inderal (propranolol) is used to treat angina, high blood pressure and heart rhythm disorders ...
Related medical questions
- How many doses are in an Ozempic pen?
- Do Ozempic, Wegovy, Mounjaro & Zepbound cause hair loss?
- How does Ozempic work for weight loss?
- What happens when you stop taking Ozempic?
- Can you switch between Ozempic and Mounjaro?
- Does Ozempic need to be refrigerated?
- Saxenda vs Ozempic: For Weight Loss?
- Will my insurance cover the cost of Ozempic?
- Can you buy Ozempic over the counter?
- When is the best time of day to take Ozempic?
- Why am I not losing weight on Ozempic?
- Does Ozempic cause muscle loss and how to prevent it?
- Where and how should Ozempic be injected?
- Rybelsus vs Ozempic for weight loss: Which to choose?
- Are there natural alternatives to Ozempic for weight loss?
- Ozempic Face: What causes it and how to prevent it?
- How long does Ozempic last in your system?
- Do GLP-1 drugs like Ozempic and Mounjaro cause sulfur burps?
- How long can you stay on Ozempic?
- How does Ozempic affect blood pressure?
- Is Ozempic better than metformin?
- Trulicity vs Ozempic: Which is right for you?
- Taking Ozempic: What foods should you avoid?
Drug information
- Ozempic Information for Consumers
- Ozempic prescribing info & package insert (for Health Professionals)
- Side Effects of Ozempic (detailed)
- Ozempic user reviews (1,543)
Related support groups
- Ozempic (107 questions, 223 members)
- Diabetes, Type 2 (502 questions, 1,428 members)
- Cancer (190 questions, 645 members)
- Cardiovascular Risk Reduction (100 questions, 28 members)